|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | (2013.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 16/22 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/06 | (2018.01) | ||
| A61P 3/08 | (2006.01) | ||
| A61P 3/08 | (2018.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 5/50 | (2006.01) | ||
| A61P 5/50 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 21/00 | (2006.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 21/06 | (2006.01) | ||
| A61P 21/06 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 19/00 | (2018.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61P 19/00 | (2006.01) |
| (11) | Number of the document | 3565592 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18701237.2 |
| Date of filing the European patent application | 2018-01-05 | |
| (97) | Date of publication of the European application | 2019-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/012686 |
| Date | 2018-01-05 |
| (87) | Number | WO 2018/129395 |
| Date | 2018-07-12 |
| (30) | Number | Date | Country code |
| 201762443455 P | 2017-01-06 | US | |
| 17150586 | 2017-01-06 | EP | |
| 201762530311 P | 2017-07-10 | US | |
| 201762608069 P | 2017-12-20 | US |
| (72) |
DONOVAN, Adriana , US
STRAUB, Michelle , US
WAWERSIK, Stefan , US
CHYUNG, Yung , US
WEBSTER, Micah , US
|
| (73) |
Scholar Rock, Inc. ,
301 Binney Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (54) | TREATING METABOLIC DISEASES BY INHIBITING MYOSTATIN ACTIVATION |
| TREATING METABOLIC DISEASES BY INHIBITING MYOSTATIN ACTIVATION |